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Objective: This study determined wound complication rates, intervention rates, failure mechanisms, patency, limb salvage,
and overall survival after lower extremity revascularization using open vein harvest (OVH) vs endoscopic vein harvest
(EVH) for critical limb ischemia.
Methods: A single-institution review was conducted of consecutive patients who underwent infrainguinal bypass with
a single-segment reversed great saphenous vein between 2005 and 2012.
Results: A total of 251 patients with critical limb ischemia underwent revascularization, comprising 153 with OVH and
98 with EVH. The OVH group had a lower mean body mass index (26.7 vs 29.9 kg/m2; P[ .001). There were no other
differences in demographics, comorbidities, medications, smoking, or in the proximal or distal anastomotic site. Median
operative times were 249 minutes (OVH) vs 316 minutes (EVH; P < .001). Median postoperative hospital length of stay
was 7 days (OVH) vs 5 days (EVH; P < .001). Median follow-up was 295 days (OVH) vs 313 days (EVH; P [ .416).
During follow-up, 21 OVH grafts (14%) and 27 EVH grafts (28%) underwent an intervention (P [ .048). There were
a similar number of surgical interventions: 50% (OVH) vs 61% (EVH; P[ .449). Failed grafts had a mean of 1.2 stenoses
per graft, regardless of harvest method. Median stenosis length was 2.1 cm (OVH) vs 2.5 cm (EVH; P[ .402). At 1 and
3 years, the primary patency was 71% and 52% (OVH) vs 58% and 41% (EVH; P[ .010), and secondary patency was 88%
and 71% (OVH) vs 88% and 64% (EVH; P[ .266). A secondary patency Cox proportional hazard model showed EVH
had a hazard ratio of 2.93 (95% conﬁdence interval, 1.03-8.33; P [ .044). Overall and harvest-related wound compli-
cations were 44% and 29% (OVH) vs 37% and 12% (EVH; P[ .226 and P[ .002). At 5 years, amputation-free survival
was 48% (OVH) vs 54% (EVH; P [ .305), and limb salvage was 89% (OVH) and 91% (EVH; P [ .615).
Conclusions:OVH and EVH have similar failure mechanisms, limb salvage, amputation-free survival, and overall survival.
EVH is associated with impaired patency, increased need for intervention, longer operative times, shorter hospital stays,
and decreased vein harvest site wound complications. OVH of the great saphenous vein may provide optimal patency but
was not necessarily associated with better patient-centered outcomes. Similar limb salvage rates and amputation-free
survival may justify the use of EVH, despite inferior patency, to capture shorter hospital stays and decreased wound
complications. (J Vasc Surg 2014;59:427-34.)Peripheral arterial disease is responsible for almost all
of the lower extremity bypasses performed each year in
the United States. Surgical bypass is the best treatment
when possible for TransAtlantic Inter-Society Consensus
D lesions due to the poor patency rates of catheter-
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with continuous incisions for great saphenous vein (GSV)
harvest can be as high as 30% to 40%.8,9
In an attempt to minimize morbidity, skip incisions
with intervening skin bridges have been used. Wound
complication rates with this approach are 3.2% to 25%.10-14
Endoscopic vein harvest (EVH) is widely used in coronary
artery bypass grafting due to a perceived reduction in
wound-related complications, improved patient satisfac-
tion, lower postoperative pain, and reduced postoperative
length of stay. Nonetheless, EVH has been used less
frequently in lower extremity bypass.15-18
Although early studies reported favorable cost, length of
stay, readmission, short-term patency, and wound complica-
tion proﬁles with EVH,8,17-21 recent publications have sug-
gested that with longer follow-up, there may be a patency
advantage in favor of traditional open vein harvest
(OVH).22,23 The literature currently provides conﬂicting
evidence on the equivalence of OVH and EVH in cardiac
and vascular surgery, an issue brought to the forefront of
national attention in 2009 when EVH was implicated
in decreased overall survival amongst coronary bypass427
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428 Santo et al February 2014patients.24 Furthermore, we are not aware of any study that
has compared the angiographic features of failing OVH and
EVH grafts performed for critical limb ischemia (CLI).
The purpose of this study was to review our lower
extremity bypass experience in CLI patients and deter-
mine if wound complication rates, limb salvage rates,
amputation-free survival, long-term patency, and overall
survival were equivalent between OVH and EVH groups.
In addition, we sought to determine if OVH and EVH
grafts failed differently by comparing angiograms of failing
grafts for stenosis location, stenosis length, and the number
of stenoses.
METHODS
The Oregon Health and Science University Institu-
tional Review Board approved the experimental protocol
in this study, and informed consent was waived due to
the retrospective nature of the study.
We reviewed our operative database to identify all
lower extremity bypasses performed with autologous vein
between January 2005 and February 2012. This interval
was chosen to correspond with the beginning of our expe-
rience with EVH. For this study, we included consecutive
bypasses that used a single GSV and were performed for
CLI.
All EVHs were performed by two authors (G.L., T.L.)
and a vascular surgery resident (postgraduate year 5-8),
using the Vasoview Endoscopic Vessel Harvesting System
(Maquet, Rastatt, Germany). When longer vein conduits
were needed for below-knee bypasses, the below-knee
vein segment was harvested through the distal anastomotic
incision. OVH usually consisted of a single continuous inci-
sion. The harvest technique used was at the discretion of
the primary attending surgeon.
All patients underwent preoperative vein mapping to
determine whether a suitable vein was available for bypass
rather than the harvest method to be used. Follow-up con-
sisted of postoperative clinic visits and duplex ultrasound
graft surveillance studies every 6 months after initial visits
at 1, 3, and 6 months.
Medical records were reviewed and all data extracted
pertaining to demographics, medical comorbidities, phys-
ical examination ﬁndings, medications, prior lower
extremity interventions, operative indication, preoperative
vein mapping, operative conduct, short-term and long-
term morbidity and mortality, preoperative and postopera-
tive angiographic features, and interventions. Primary
patency, primary assisted patency, secondary patency,
limb salvage, amputation-free survival, and overall survival
were calculated from records.
Renal insufﬁciency was deﬁned as a mean serum creat-
inine >1.5 mg/dL at the time of the operation. Medica-
tion proﬁles were those at the time of the initial
consultation. Patients were categorized as former smokers
if they had quit >8 weeks before the operation.
Preoperative vein mapping was performed by an ac-
credited vascular laboratory, and minimum and maximum
reported diameters were taken from ofﬁcial diagnosticreports. Pulses were categorized as palpable when docu-
mented as palpable, strong, or 2þ. Operative conduct
was gathered from operative notes, and operative times
were calculated from anesthesia records. Surgical incision
and surgical end times were used rather than anesthesia
start and stop times. Grafts were preferentially tunneled
anatomically, except for those originating in the proximal
thigh and going to the anterior tibial artery, which were
tunneled subcutaneously.
Postoperative wound complications were deﬁned
according to Szilagyi criteria.25 Wound complications
were further categorized as “vein harvest” or “anastomotic
incision.” Vein harvest complications included those
described as being remote from anastomotic site incisions
or when notes speciﬁcally referenced the “harvest incision”
or the endoscopic tunnel.
Major amputations included any below-knee or above-
knee amputation, and minor amputations included toe or
partial foot amputations. Patency was deﬁned according
to established Society for Vascular Surgery standards for
graft patency reporting.26 Arteriograms were obtained in
all patients before anticipated bypass revisions, as prompted
by clinical change or surveillance duplex ﬁndings suggestive
of stenosisdfocal peak systolic velocity >200 cm/s,
systolic velocity ratio >3.0, midgraft velocity <45 cm/s,
or an interval drop in the ankle-brachial index of $0.2.27
Failure mechanisms were determined by reviewing
arteriograms for location, number, and length of stenoses.
A single stenosis #4 cm was categorized as a “single-
segment” failure, two or more discrete lesions were re-
ported as a “multisegment” failure, and a single lesion
>4 cm was reported as a “long-segment” failure. We
deﬁned loss to follow-up as 18 months without a clinic visit
or correspondence.
Categoric variables were analyzed using c2 or the
Fisher exact test. Continuous variables were analyzed using
the unpaired Student t-test or Mann-Whitney test. Nor-
mally distributed variables are expressed as means 6 stan-
dard deviation, and nonparametric variables are expressed
as medians and interquartile range (IQR). Time-to-event
variables were analyzed using the log-rank test of Kaplan-
Meier analysis. Cox proportional hazard modeling was per-
formed on selected time-to-event outcome variables.
Statistical analyses were performed using SPSS 21 software
(IBM Corp, Armonk, NY). Signiﬁcance was set at P ¼ .05,
and two-sided values are reported where applicable.RESULTS
Between January 2005 and February 2012, 382 lower
extremity bypasses were performed with autologous vein,
251 of which were performed with a single GSV for CLI.
The remaining 131 patients were excluded because 64
had a bypass with arm vein, 56 had a bypass for claudica-
tion, 5 had bilateral open GSV harvest, 2 had a GSV bypass
for trauma, 2 had a GSV bypass for popliteal aneurysms,
and 2 had a GSV bypass for infection of a prosthetic bypass
performed at another institution.
Table I. Baseline characteristics and comorbidities
Variables OVH (n ¼ 153) EVH (n ¼ 98) P
Sexa .973
Male 94 (61.4) 60 (61.2)
Female 59 (38.6) 38 (38.8)
Age,b years 66.7 6 13.7 65.7 6 9.8 .470
BMI,b kg/m2 26.7 6 6.6 29.9 6 7.2 .001
Hypertensiona 125 (81.7) 77 (78.6) .542
Hyperlipidemiaa 60 (39.2) 41 (41.8) .680
DMa
IDDM 43 (28.1) 25 (25.5) .652
NIDDM 34 (22.2) 27 (27.6) .337
CADa 62 (40.5) 42 (42.9) .714
Dialysisa 22 (14.4) 13 (13.3) .804
COPDa 19 (12.4) 10 (10.2) .592
Tobacco usea
Current 56 (36.6) 47 (48.0) .074
Prior 60 (39.2) 34 (34.7) .470
Palpable pulsesa
Femoral 103 (71.5) 62 (63.9) .451
Popliteal 18 (12.4) 9 (9.3) .101
Pedal 1 (0.7) 1 (1.0) .214
Antiplateleta 100 (65.4) 58 (59.2) .323
Aspirin 90 (58.8) 52 (53.1) .369
Clopidogrel 28 (18.3) 19 (19.4) .829
Statina 71 (46.4) 42 (42.9) .581
Coumadina,c 23 (15.0) 9 (9.2) .175
BMI, Body mass index; CAD, coronary artery disease; COPD, chronic
obstructive pulmonary disease; DM, diabetes mellitus; EVH, endoscopic
vein harvest; IDDM, insulin-dependent diabetes mellitus; NIDDM,
noninsulin-dependent diabetes mellitus; OVH, open vein harvest.
aNo. (%), c2 analysis.
bMean 6 standard deviation, unpaired Student t-test, two-tailed analysis.
cBristol-Myers Squibb, Princeton, New Jersey.
Table II. Inﬂow and outﬂow artery
Artery
OVH (n ¼ 153),
No. (%)
EVH (n ¼ 98),
No. (%) P
Arterial inﬂowa
EIA 3 (2.0) 1 (1.0) .562
CFA 57 (37.3) 46 (46.9) .128
Profunda femoris 21 (13.7) 13 (13.3) .917
SFA 44 (28.8) 19 (19.4) .095
AK popliteal 6 (3.9) 2 (2.0) .488
BK popliteal 16 (10.5) 9 (9.2) .742
Aortofemoral graft 1 (0.7) 3 (3.1) .302
Iliofemoral graft 0 (0.0) 2 (2.0) .151
Axillary-femoral graft 3 (2.0) 1 (1.0) >.99
Femoral-femoral graft 2 (1.3) 2 (2.0) .645
Arterial outﬂowa
AK popliteal 20 (13.1) 8 (8.2) .228
BK popliteal 47 (30.7) 39 (39.8) .139
TP trunk 1 (0.7) 2 (2.0) .562
Posterior tibial 30 (19.6) 17 (17.3) .741
Anterior tibial 24 (15.7) 13 (13.3) .598
Peroneal 24 (15.7) 13 (13.3) .716
Pedal 7 (4.6) 6 (6.2) .550
AK, Above-knee; BK, below-knee; CFA, common femoral artery; EIA,
external iliac artery; EVH, endoscopic vein harvest; OVH, open vein harvest;
SFA, superﬁcial femoral artery; TP, tibioperoneal.
ac2 analysis.
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in 98 patients. The baseline demographic information
for the two groups is presented in Table I. The EVH
group had a higher body mass index, but there were other-
wise no signiﬁcant differences. Median follow-up was
295 days (IQR, 70-798 days) for OVH and 313 days
(IQR, 93-930 days) for EVH (P ¼ .416). All patients
completed at least one postoperative visit. Ultimately, 61
patients (40%) in the OVH group and 45 (46%) in the
EVH group were lost to follow-up (P ¼ .344). Of those
lost to follow-up, median follow-up for each group was
still >100 days.
Bypasses were performed for tissue loss in 118 OVH
patients (77%) and in 69 EVH patients (70%; P ¼ .234).
The anatomic distribution of these wounds was no
different between groups. Fifty-one OVH patients (33%)
had prior ipsilateral open or endovascular interventions
compared with 25 EVH patients (26%; P ¼ .188). In the
OVH group, there was one prior endarterectomy and 26
prior bypasses. The distal arterial anastomosis in these prior
bypasses was popliteal in 15, femoral in 6, tibial in 4, or
unknown in 1. In the EVH group, there were two prior
endarterectomies and 14 prior bypasses. The distal arterial
anastomosis in these prior bypasses was popliteal in 10,
femoral in 3, or tibial in 1. These differences were not
statistically signiﬁcant.Prior endovascular interventions in the OVH group
included 8 pelvic stents, 4 infrainguinal stents, 5 infraingui-
nal angioplasties, 5 crural angioplasties, and 7 combina-
tion thrombectomy-thrombolysis-atherectomy procedures.
Prior endovascular interventions in the EVHgroup included
4 pelvic stents, 1 infrainguinal stent, 3 crural angioplasties,
and 3 thrombectomy-thrombolysis-atherectomy proce-
dures. These differences were also were not signiﬁcant. Of
those who had a prior intervention, the mean number was
1.6 6 1.1 in the OVH group and 1.5 6 0.7 in the EVH
group (P ¼ .751).
Arterial inﬂow and outﬂow vessels are noted in Table II
and were not different between groups. Mean minimum
vein diameter on preoperative vein mapping was 3.3 6
0.9 mm in OVH and 3.3 6 0.8 mm in EVH (P ¼
.456). Mean maximum vein diameter was 5.9 6 1.6 mm
in OVH and 6.8 6 1.8 mm in EVH (P < .001). Six
OVH grafts (4%) and 11 EVH grafts (11%) required
a venovenostomy for stenosis or injury to the conduit
(P ¼ .025).
No differences were noted in additional procedures
performed at the index operation. Two OVH bypasses
(1%) and one EVH bypass (1%) underwent angioplasty
without stenting (P > .99). One was for an outﬂow tibial
vessel in the OVH group and the other two for inﬂow
stenosis. Stent placement was required in eight OVH
bypasses (5%) and two EVH bypasses (2%; P ¼ .324) in
conjunction with the original procedure. All were pregraft
inﬂow stents in the aortoiliac segment, except one in the
OVH group that extended to the common femoral artery.
A simultaneous endarterectomy was done in 21 OVH
procedures (14%) and in 13 EVH procedures (13%; P ¼
.917). Four in the OVH group were performed distally,





(n ¼ 98) P
Mortality (30-day)a 7 (4.6) 3 (3.1) .550
Length of stay, daysb
Overall hospital 10 (7-17) 7 (4-12) <.001
Postoperative 7 (5-13) 5 (4-8) <.001
Complications at 30 daysa
MI 4 (2.7) 6 (6.5) .192
Pneumonia 3 (2.0) 1 (1.1) >.99
UTI 4 (2.7) 2 (2.2) >.99
CVA 4 (2.7) 1 (1.1) .651
Any wound complicationa 68 (44.4) 36 (36.7) .226
Vein harvest incision complicationa 43 (29.1) 11 (11.8) .002
Anastomotic incision complicationa 29 (19.6) 27 (29.0) .091
CVA, Cerebrovascular accident; EVH, endoscopic vein harvest; IQR,
interquartile range; MI, myocardial infarction; OVH, open vein harvest;
UTI, urinary tract infection.
aNo. (%), c2 analysis.
bMedian (IQR), Mann-Whitney analysis.
Fig 1. Primary patency is shown for open vein harvest (OVH) vs
endoscopic vein harvest (EVH). Patients at risk are shown above
the x-axis.
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Median operative time was 249 minutes (IQR, 192-
325 minutes) for OVH and 316 minutes (IQR, 257-
373 minutes) for EVH (P < .001).
Median overall hospital length of stay was 3 days
shorter in the EVH group, and median postoperative
hospital length of stay was 2 days shorter in the EVH group
(Table III).
Vein harvest wound complications occurred more than
twice as frequently in OVH patients (Table III). Consid-
ering harvest and anastomotic incision complications
together as “any wound complication,” any advantage for
EVH was no longer statistically signiﬁcant (Table III).
There was no difference in myocardial infarction, pneu-
monia, urinary tract infection, cerebrovascular accident, or
30-day mortality between the groups (Table III). Among
OVH wound complications, 62% were class I, 34% were
class II, and 4% were class III. Among EVH wound
complications, 58% were class I, 39% were class II, and
3% were class III. Differences were statistically insigniﬁcant
(P ¼ .349).
Wounds required operative management in 22 OVH
(32%) and 14 EVH (39%) wound complications (P ¼
.505). All of the 22 OVH wound complications managed
operatively required debridement, without ﬂap placement
or graft revision. Of the 22 complications, 15 required
one operation, four required two operations, and three
required three operations. Among the 14 EVH wound
complications managed operatively, all required debride-
ment, two required a rectus femoris ﬂap, three required
a sartorius ﬂap, and two required a graft revision. All ﬂaps
were placed for anastomotic incision complications. Of
the 14 complications, 6 required one operation, 2 required
two operations, 1 required three operations, 1 required
four operations, and 1 required ﬁve operations. Approxi-
mately 43% of anastomotic incision complications required
operative management vs 24% of vein harvest incision
complications (P ¼ .041), and median hospital stay wasw3.5 days longer in patients who required operative
management (P ¼ .013).
At 1 and 3 years, primary patency was 71% and 52% in
OVH vs 58% and 41% in EVH (P ¼ .010; Fig 1), respec-
tively, and secondary patency was 88% and 71% in OVH vs
88% and 64% in EVH (P ¼ .266; Fig 2). A Cox propor-
tional hazard model was ﬁtted using factors implicated in
previous reports with impaired patency in addition to
univariate factors with a P value < .2. In this model,
EVH was predictive of failed secondary patency, with
a hazard ratio of 2.93 (95% conﬁdence interval, 1.029-
8.332; Table IV). This model also found stenting at the
initial operation and more distal outﬂow vessels were two
factors predictive of patency loss, whereas increasing body
mass index was protective. At 5 years, limb salvage was
89% in OVH and 91% in EVH (P ¼ .615; Fig 3) and
amputation-free survival was 48% in OVH and 54% in
EVH (P ¼ .305; Fig 4). Overall survival was no different
between the groups (P ¼ .383; Fig 5). All standard errors
were <0.10, with more than ﬁve patients at risk for re-
ported time intervals.
There were 15 major amputations in the OVH group
(10%) vs eight in the EVH group (8%; P ¼ .971). Minor
amputation occurred in 45 OVH patients (36%) and in 25
EVH patients (26%; P ¼ .015). In the OVH group, 35
(57%) had planned amputations that occurred during the
initial hospitalization vs 15 (46%) in the EVH group (P ¼
.269). Seven patients in the OVH group with minor ampu-
tations later required a major amputation. Progressive
gangrene was the leading cause of any amputation in both
groupsd22OVHamputations (36%) and 17EVH amputa-
tions (52%). Uncontrolled infection was the second leading
caused20 OVH (33%) and seven EVH (21%). The rest
were caused by stable gangrene, necrosis, unreconstructable
ischemia after graft failure, and thromboembolism.
During the course of the study period, 21 OVH grafts
(14%) and 27 EVH grafts (28%) underwent intervention
Fig 2. Secondary patency is shown for open vein harvest (OVH)
vs endoscopic vein harvest (EVH). Patients at risk are shown above
the x-axis.
Table IV. Cox proportional hazard model for secondary
patency loss
Variable HR (95% CI) P
EVH 2.93 (1.029-8.332) .044
Female gender 1.319 (0.449-3.901) .617
BMI, kg/m2 0.911 (0.834-0.995) .038
COPD 4.111 (0.902-18.732) .068
IDDM 0.478 (0.115-1.982) .309
NIDDM 0.214 (0.042-1.080) .062
CKD 1.042 (0.249-4.359) .955
Current smoker 0.909 (0.281-2.939) .874
Antiplatelet 2.891 (0.841-9.941) .092
Anticoagulation 2.164 (0.566-8.279) .259
Inﬂow a .489
Outﬂow a .002
Minimum vein size, mm 1.181 (0.628-2.222) .606
Stent at index operation 10.168 (1.253-82.492) .030
BMI, Body mass index; CI, conﬁdence interval; CKD, chronic kidney
disease; EVH, endoscopic vein harvest; HR, hazard ratio; IDDM, insulin-
dependent diabetes mellitus; NIDDM, noninsulin dependent diabetes
mellitus.
aInﬂow vessels were not signiﬁcant predictors of secondary patency loss.
Peroneal and pedal artery outﬂow vessels were associated with HRs of 51 to
3323 (95% CI, 2.0-106,371).
Fig 3. Limb salvage is shown for endoscopic vein harvest (EVH)
vs open vein harvest (OVH). Patients at risk are shown above the
x-axis.
Fig 4. Amputation-free survival is shown for endoscopic vein
harvest (EVH) vs open vein harvest (OVH). Patients at risk are
shown above the x-axis.
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intervened upon grafts that required operative treatment
(50% of OVH vs 61% of EVH; P ¼ .449), angioplasty
(73% of OVH vs 54% of EVH; P ¼ .166), stent placement
(5% of OVH vs 7% of EVH; P ¼ .701), thrombectomy
(14% of OVH vs 14% of EVH; P ¼ .948), or thrombolysis
(18% of OVH vs 7% of EVH; P ¼ .233).
Apart from those grafts that required intervention, an
additional 14 OVH grafts and 10 EVH grafts thrombosed
and were abandoned or did not have an intervention,
yielding failure data on 35 OVH grafts and 37 EVH grafts.
There was no difference in failure mechanism between the
two groups (Table V). Angiographic measurements wereavailable for 16 of 16 OVH and 19 of 19 EVH stenoses.
Failing grafts had a mean of 1.2 6 0.4 stenoses per graft,
regardless of harvest method. The median stenosis length
was 2.1 cm (IQR, 0.9-2.7 cm) for OVH and 2.5 cm
(IQR, 1.0-4.0 cm) for EVH (P ¼ .402).
DISCUSSION
Our study provides outcomes data comparing OVH
and EVH from a large series of lower extremity bypasses
performed for CLI at a tertiary referral center. In this pop-
ulation of CLI patients, we found a patency advantage for
OVH compared with EVH. Unlike the cardiac literature,
randomized data do not exist in vascular patients, and
previous series have shown mixed results. Gazoni et al20
analyzed 88 patients and found no signiﬁcant difference
in primary patency at 21 months and reported a trend
Fig 5. Overall survival is shown for endoscopic vein harvest
(EVH) vs open vein harvest (OVH). Patients at risk are shown
above the x-axis.








Single segment stenosis 12 (34.3) 13 (35.1) .940
Proximal anastomosisb 6 (17.1) 9 (24.3) .453
Distal anastomosisb 1 (2.9) 1 (2.7) >.99
Midgraftb 5 (14.3) 5 (13.5) >.99
Multisegment stenosis 4 (11.4) 4 (10.8) >.99
Long-segment stenosis (>4 cm) 0 (0.0) 2 (5.4) .163
Complete thrombosis/abandoned 14 (40.0) 8 (21.6) .126
Technical error 1 (2.9) 2 (5.4) >.99
Inﬂow-outﬂow issue 4 (11.4) 8 (21.6) .346
EVH, Endoscopic vein harvest; OVH, open vein harvest.
ac2 analysis.
bSubclassiﬁcations of single segment failure pattern.
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compared a single surgeon’s 10-year transition from stan-
dard incision in 133 to skip incision in 106 to endoscopic
harvest in 85. Primary patency for the standard incision
was signiﬁcantly better than skip incisions or endoscopic
harvestd59% vs 33% or 44%.23 Illig et al8 found no differ-
ence in 1-year patency for 214 patients. On the basis of
newly emerging data, however, a reanalysis of this cohort
with an additional 149 patients refuted their initial ﬁndings
and, in 363 patients, showed inferior patency rates with
EVH.22 Unique to the Julliard et al22 series, this difference
disappeared when they limited their analysis to nondiabetic
or claudicant patients. Our data clearly found OVH was
associated with superior patency compared with EVH.
Inferior patency rates were reﬂective, not surprisingly,
of an increased need for intervention among EVH grafts
during the study period. Any patency advantage for
OVH notwithstanding, univariate analysis or Cox propor-
tional hazard modeling found no difference in overall
survival, amputation-free survival, or limb salvage between
the two groups. So although traditional measurements of
graft integrity may be compromised, the most relevant
patient-centered outcomes, such as limb salvage and
amputation-free survival, appear less affected and, there-
fore, could justify continued broad application of EVH.
Stent placement during the index procedure was also
predictive of loss of secondary patency and likely represents
more severe disease burden in these patients compared
with those who did not require stenting.
An important concern about the technical aspect of
EVH is the need for increased vein manipulation compared
with OVH and the potential risk of associated endothelial
damage. This risk of endothelial disruption has been shown
in studies that document the negative effect of EVH on
graft esterase activity, calcium mobilization, nitric oxide
production, multiphoton microscopic appearance, and
immunoﬂuorescence.28 The “no-touch” approach has
also been shown to improve vasovasorum and adventitialintegrity.29 In this series, EVH was more frequently associ-
ated with vein trauma, as reﬂected in the higher number of
venovenostomies required, although most of the failing
grafts developed a short, single-segment stenosis irrespec-
tive of harvest method. The length, number, and site of
vein graft stenoses were not statistically different between
the two groups, suggesting that any microscopic damage
associated with harvest method may not translate to clinical
impact in the mechanism of graft failure.
Despite the close postoperative follow-up and duplex
surveillance, w20% to 40% of failing grafts presented as
occlusions, and despite optimizing graft inﬂow and
outﬂow, 10% to 20% of failing grafts were caused by a “non-
graft” lesion. These facts highlight the challenges inherent
in surveillance as well as the importance of good inﬂow and
outﬂow for maintaining graft patency.
The major stimulus for EVH is to decrease the wound
burden associated with OVH. Because OVH and EVH
both require anastomotic incisions, we looked at complica-
tions related to the anastomotic incision separately from
complications related to the vein harvest. In univariate
analysis, there was a signiﬁcant advantage to endoscopic
harvest when looking only at incisions related to the
harvest. Because many wound complications involve the
anastomotic incisions, the potential advantage for EVH
with respect to wound complications appeared to be
negated in univariate analysis of “all wound complica-
tions.” Multivariate logistic regression in this patient popu-
lation did not show OVH was an independent risk factor
for any wound complication. Previous studies have docu-
mented as much as a sixfold increase in overall wound
complications for OVH (23% vs 4%),18 whereas others
cite similar wound complication rates.17,20,22 Our data
appear consistent with the former.
Operative times were signiﬁcantly shorter and the
hospital stay was 2 to 3 days longer in the OVH group.
We believe that these two factors would be the major issues
in considering any cost analysis and are consistent with
prior reports.8,17,18 There would be upfront costs for the
harvesting system and continued investment in disposable
equipment inventory as well as sterile processing. In our
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cardiac surgery department and because attending and resi-
dent surgeons performed the harvest rather than a physi-
cian’s assistant, no additional personnel costs were
incurred. Whether the upfront costs, continuing costs, and
increased operating room time for EVH equal potential
savings of shorter hospital stays and fewer revisions is an
important question. We believe the complexities of cost
analysis on a retrospective cohort such as this would render
any information potentially misleading and were thus
beyond the scope of this study.
One possible reason that OVH had longer hospital
stays is that more minor amputations were performed in
the OVH group, although the number of planned amputa-
tions performed during the index hospital stay were similar.
Wound burden on presentation was similar. We were
unable to include insurance status in our analysis and so
could not control for its contribution to length of stay.
We speculate that decreased mobility associated with
OVH could have at least partly contributed to longer
hospital stays, although we have no objective measures to
support such a claim.
The limitations of our study include its retrospective
nature and lack of randomization. The deciding factor in
whether a patient had an open or endoscopic harvest was
largely dependent on the attending surgeon’s preference,
so the presence of a selection bias could not be avoided.
Related to surgeon bias is the learning curve associated
with EVH. Although the EVH was supervised by the
attending physician, a vascular trainee generally performed
at least some portion of the EVH. Desai et al20 showed that
novice technicians were more likely to cause vessel injury
during harvest, so better outcomes for EVH could emerge
if a dedicated, experienced harvester was used in all cases.30
Despite its limitations, we believe that EVH will
continue to have a role in vascular surgery but will require
more selective application in speciﬁc patient groups. In our
practice, EVH is still used in cases where a contralateral
vein is harvested, in cases where EVH will spare an incision
in the inguinal crease as a result of distal inﬂow source (eg,
distal superﬁcial femoral artery, profunda, or popliteal), and
in cases with patients felt to be at high risk for wound
complications, including obese patients or those with active
foot infections.
On the basis of our experience, vein position is also an
important factor. A GSV that is contained within the
saphenous fascial envelope is more straightforward for
EVH compared with those located primarily in the subcu-
taneous fat. We were unable to retrospectively collect these
data to enter in our analysis, but it has emerged as a factor
in our decision making.
CONCLUSIONS
This study demonstrates that in a population of CLI
patients treated with lower extremity bypass, EVH is asso-
ciated with an increased need for graft intervention,
impaired patency, and longer operative times. Limb
salvage, amputation-free survival, overall survival, and theanatomic patterns of graft failure were similar between
harvest methods. Equivalence in these patient-centered
outcomes may justify the use of EVH to capture shorter
hospital stays and fewer wound complications in selected
patients. A multi-institution randomized trial is needed to
deﬁnitively evaluate the efﬁcacy of vein harvest procedures
as adjuncts in lower extremity bypass.
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